Photo-control of the interaction between endothelial cells and photo-cation generatable water-soluble polymers

Journal of Controlled Release

Volumn 89, Issue 2, 2003, Pages 213-224

  Nakayama, Yasuhide ^a   Matsuda, Takehisa ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell polymer interaction; Drug modification; Malachite green; Photo cation generatable polymer; Photo control

Indexed keywords

COPOLYMERIZATION; FREE RADICAL POLYMERIZATION; IRRADIATION; POLYMERS; POSITIVE IONS; ULTRAVIOLET RADIATION;

PHOTO-CONTROL;

CELLS;

ACRYLAMIDE; AEQUORIN; BUFFER; CALCIUM ION; CATION; COPOLYMER; DIPHENYL(4 VINYLPHENYL)METHANE LEUCOHYDROXIDE; HYDROXIDE; ION; MALACHITE GREEN; PHOTOPROTEIN; POLYMER; TRITYL DERIVATIVE; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATTLE; CELL CULTURE; CELL DAMAGE; CELL INTERACTION; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; DISSOCIATION; ENDOTHELIUM CELL; LUMINESCENCE; NONHUMAN; PHOTOREACTIVITY; POLYMERIZATION; PRIORITY JOURNAL; SOLUBILITY; ULTRAVIOLET IRRADIATION;

EID: 0037472131     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00088-9     Document Type: Article

References (35)

1. Kojima Y., Haruta A., Imai T., Otagiri M., Maeda H. Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: pharmacological activity and cell-lubricating function. Bioconjug. Chem. 4:1993;490-498.
2. Wong K., Cleland L.G., Poznansky M.J. Enhanced anti-inflammatory effect and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin. Agents Actions. 10:1980;231-239.
3. Wulbrand U., Feldman M., Pfestroff A., Fehman H.C., Du J., Hiltunen J., Marquez M., Arnold R., Westlin J.E., Nilsson S., Holmberg A.R. A novel somatostatin conjugate with a high affinity to all five somatostatin receptor subtypes. Cancer. 94:2002;1293-1297.
4. Sakurai K., Miyazaki K., Kodera Y., Nishimura H., Shingu M., Inada Y. Anti-inflammatory activity of superoxide dismutase conjugated with sodium hyaluronate. Glycoconj. J. 14:1997;723-728.
5. Mier W., Eritja R., Mohammed A., Haberkorn U., Eisenhut M. Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates. Bioconjug. Chem. 11:2000;855-860.
6. Astriab-Fisher A., Sergueev D.S., Fisher M., Shaw B.R., Juliano R.L. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharmacol. 60:2000;83-90.
7. Caliceti P., Schiavon O., Veronese F.M. Immunological properties of uricase conjugated to neutral soluble polymers. Bioconj. Chem. 12:2001;515-522.
8. Mu Y., Kamada H., Kodaira H., Sato K., Tsutsumi Y., Maeda M., Kawasaki K., Nomizu M., Yamada Y., Mayumi T. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life. Biochem. Biophys. Res. Commun. 264:1999;763-767.
9. Ranucci E., Spagnoli G., Ferruti P., Sgouras D., Duncan R. Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicity. J. Biomater. Sci. Polym. Ed. 2:1991;303-315.
10. Molineux G. Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat. Rev. 28:(Suppl. A):2002;13-16.
11. Bukowski R.M., Tendler C., Cutler D., Rose E., Laughlin M.M., Statkevich P. Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation. Cancer. 95:2002;389-396.
12. Sato H. Enzymatic procedure for site-specific pegylation of proteins. Adv. Drug Deliv. Rev. 54:2002;487-504.
13. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54:2002;459-476.
14. Wang Y.S., Youngster S., Grace M., Bausch J., Bordens R., Wyss D.F. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv. Drug Deliv. Rev. 54:2002;547-570.
15. Hershfield M.S. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin. Hematol. 35:1998;291-298.
16. Sanders N.N., De Smedt S.C., Cheng S.H., Demeester J. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther. 9:2002;363-371.
17. Chua C.C., Greenberg M.L., Viau A.T., Nucci M., Brenckman W.D. Jr., Hershfield M.S. Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma. Ann. Intern. Med. 109:1988;114-117.
18. Taylor C.W., Dorr R.T., Fanta P., Hersh E.M., Salmon S.E. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 47:2001;83-88.
19. Kaplan B., Moy R.L. Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. Dermatol. Surg. 26:2000;1037-1040.
20. Muizelaar J.P. Clinical trials with Dismutec (pegorgotein; polyethylene glycol-conjugated superoxide dismutase; PEG-SOD) in the treatment of severe closed head injury. Adv. Exp. Med. Biol. 366:1994;389-400.
21. Mu Y., Kamada H., Kaneda Y., Yamamoto Y., Kodaira H., Tsunoda S., Tsutsumi Y., Maeda M., Kawasaki K., Nomizu M., Yamada Y., Mayumi T. Bioconjugation of laminin peptide YIGSR with poly(styrene co-maleic acid) increases its antimetastatic effect on lung metastasis of B16-BL6 melanoma cells. Biochem. Biophys. Res. Commun. 255:1999;75-79.
22. Y. Tsutsumi, T. Matsuda, T. Mayumi, Fundamental study on hybrid drug design: interaction of water-soluble polymers with endothelial cells by means of cytosolic calcium ion mobilization (in preparation).
23. Kojima T., Hashida M., Muranishi S., Sezaki H. Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin C. J. Pharm. Pharmacol. 32:1980;30-34.
24. Sezaki H., Hashida M. Macromolecule-drug conjugates in targeted cancer chemotherapy. Crit. Rev. Ther. Drug Carrier. Syst. 1:1984;1-38.
25. Johnson P.C., Ware J.A., Cliveden P.B., Smith M., Dvorak A.M., Salzman E.W. Measurement of ionized calcium in blood platelets with the photoprotein aequorin. Comparison with Quin 2. J. Biol. Chem. 260:1985;2069-2076.
26. Lecompte T., Potevin F., Champeix P., Morel M.C., Favier R., Hurtaud M.F., Schlegel N., Samama M., Kaplan C. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP. Thromb. Res. 58:1990;561-570.
27. Shimomura O., Johnson F.H. Properties of the bioluminescent protein aequorin. Biochemistry. 8:1969;3991-3997.
28. Shimomura O., Johnson F.H. Calcium binding, quantum yield, and emitting molecule in aequorin bioluminescence. Nature. 227:1970;1356-1357.
29. Bertelson R.C. Brown G.H. Photochromism. Techniques of Chemistry. Vol. III:1971;294 Wiley-Interscience, New York.
30. Irie M., Kungwatchakun D. Reversible photostimulated dilation of polyacrylamide gels having triphenylmethane leucoderivatives. Macromolecules. 19:1986;2476.
31. Yamaguchi A., Suzuki H., Tanoue K., Yamazaki H. Simple method of aequorin loading into platelets using dimethyl sulfoxide. Thromb. Res. 44:1986;165-174.
32. Medzihradsky F., Marks M.J. Measures of viability in isolated cells. Biochem. Med. 13:1975;164-177.
33. Aveldano M.I., Diaz R.S., Regueiro P., Monreal J. Solubilization of myelin membranes by detergents. J. Neurochem. 57:1991;250-257.
34. Allen D.G., Blinks J.R., Prendergast F.G. Aequorin luminescence: relation of light emission to calcium concentration: a calcium-independent component. Science. 195:1977;996-998.
35. Ryser H.J. Uptake of protein by mammalian cells: an underdeveloped area. The penetration of foreign proteins into mammalian cells can be measured and their functions explored. Science. 159:1968;390-396.